The implantable cardiac devices market size has grown strongly in recent years. It will grow from $13.34 billion in 2025 to $14.51 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing prevalence of cardiac arrhythmias, rising aging population, expansion of hospital cardiac care infrastructure, adoption of pacemaker technologies, availability of advanced implantable devices.
The implantable cardiac devices market size is expected to see strong growth in the next few years. It will grow to $20.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising focus on minimally invasive cardiac treatments, expansion of digital healthcare integration, growing innovation in battery and lead technologies, increasing use of ai-assisted cardiac diagnostics. Major trends in the forecast period include increasing adoption of miniaturized implantable devices, rising integration of remote cardiac monitoring, growing use of mri-compatible implants, expansion of cardiac resynchronization therapies, enhanced focus on device longevity and reliability.
The rising prevalence of heart diseases is expected to drive the growth of the implantable cardiac devices market. This increase in heart conditions is largely due to the growing occurrence of risk factors such as unhealthy diets, sedentary lifestyles, obesity, and chronic illnesses like diabetes and hypertension. Additionally, aging populations and higher stress levels further contribute to the surge in cardiovascular conditions. Implantable cardiac devices are employed to manage and treat heart failure, arrhythmias, and coronary artery disease. The growing demand for these devices is accelerating innovation and investment in developing advanced cardiac solutions to address the expanding patient base and improve treatment outcomes. For example, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart disease caused 5,302 deaths in May 2024, slightly increasing from 5,290 deaths in 2022. Consequently, the rising incidence of heart diseases is driving the expansion of the implantable cardiac devices market.
Companies in the implantable cardiac devices sector are focusing on technological innovations to improve compatibility with diagnostic tools such as AutoMRI, enhancing device longevity and patient safety. The AutoMRI feature in implantable cardiac defibrillators automatically adjusts device settings during MRI scans, allowing patients to safely access advanced imaging technology while receiving optimal care. For instance, in October 2023, MicroPort CRM, a France-based medical device company, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These devices incorporate advanced technology with low power consumption for extended lifespan and MRI compatibility. The ULYS ICD features the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead provides precise pacing and defibrillation therapy, demonstrating a 100% implantation success rate and a 97.4% complication-free rate in clinical trials.
In November 2023, Johnson & Johnson MedTech, a US-based medical-technology company, acquired Laminar Inc. for $400 million. This acquisition strengthens Johnson & Johnson MedTech’s position in the structural-heart and left-atrial-appendage management market by integrating Laminar’s investigational LAAX left-atrial-appendage elimination technology into its portfolio. It also enhances the company’s ability to reduce stroke risk in atrial fibrillation patients through the addition of an innovative implantable cardiac device solution. Laminar Inc. is a US-based manufacturer of implantable cardiac devices.
Major companies operating in the implantable cardiac devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, LifeTech Scientific Corporation, EBR Systems Inc., CVRx Inc., Medico S.p.A., Osypka Medical GmbH, Sorin Group Italia (LivaNova legacy), Shree Pacetronix Ltd., Inpace Medikal, CCC Medical Devices, Imricor Medical Systems Inc., BlueWind Medical Ltd., Vectorious Medical Technologies, Medico Electrodes International Ltd.
North America was the largest region in the implantable cardiac devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the implantable cardiac devices market by increasing costs of imported semiconductors, sensors, batteries, titanium casings, and precision electronic components used in pacemakers and defibrillators. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are raising device prices and procurement costs for healthcare providers. However, they are also encouraging domestic production, localized assembly, and regional innovation in implantable cardiac technologies.
The implantable cardiac devices market research report is one of a series of new reports that provides implantable cardiac devices market statistics, including implantable cardiac devices industry global market size, regional shares, competitors with a implantable cardiac devices market share, detailed implantable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable cardiac devices industry. This implantable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Implantable cardiac devices are medical instruments that are surgically inserted into the body to assist in the management of heart disorders, especially those associated with irregular heart rhythms (arrhythmias) or heart failure. These devices monitor cardiac activity and often provide electrical impulses to regulate or correct abnormal heartbeats.
The primary categories of implantable cardiac devices consist of pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular implantable cardioverter defibrillators (BI-V ICDs). A pacemaker is a compact medical device positioned beneath the skin in the chest area, designed to manage irregular heartbeats by delivering electrical impulses that prompt the heart to maintain a normal rhythm when its natural pacemaker is inadequate. This device is essential in treating conditions such as bradycardia and various arrhythmias. Applications for these devices encompass bradycardia, tachycardia, heart failure, among others, catering to end users such as hospitals, specialty clinics, and more.
The implantable cardiac devices market consists of sales of products including cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and implantable heart monitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The implantable cardiac devices market size is expected to see strong growth in the next few years. It will grow to $20.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising focus on minimally invasive cardiac treatments, expansion of digital healthcare integration, growing innovation in battery and lead technologies, increasing use of ai-assisted cardiac diagnostics. Major trends in the forecast period include increasing adoption of miniaturized implantable devices, rising integration of remote cardiac monitoring, growing use of mri-compatible implants, expansion of cardiac resynchronization therapies, enhanced focus on device longevity and reliability.
The rising prevalence of heart diseases is expected to drive the growth of the implantable cardiac devices market. This increase in heart conditions is largely due to the growing occurrence of risk factors such as unhealthy diets, sedentary lifestyles, obesity, and chronic illnesses like diabetes and hypertension. Additionally, aging populations and higher stress levels further contribute to the surge in cardiovascular conditions. Implantable cardiac devices are employed to manage and treat heart failure, arrhythmias, and coronary artery disease. The growing demand for these devices is accelerating innovation and investment in developing advanced cardiac solutions to address the expanding patient base and improve treatment outcomes. For example, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart disease caused 5,302 deaths in May 2024, slightly increasing from 5,290 deaths in 2022. Consequently, the rising incidence of heart diseases is driving the expansion of the implantable cardiac devices market.
Companies in the implantable cardiac devices sector are focusing on technological innovations to improve compatibility with diagnostic tools such as AutoMRI, enhancing device longevity and patient safety. The AutoMRI feature in implantable cardiac defibrillators automatically adjusts device settings during MRI scans, allowing patients to safely access advanced imaging technology while receiving optimal care. For instance, in October 2023, MicroPort CRM, a France-based medical device company, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These devices incorporate advanced technology with low power consumption for extended lifespan and MRI compatibility. The ULYS ICD features the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead provides precise pacing and defibrillation therapy, demonstrating a 100% implantation success rate and a 97.4% complication-free rate in clinical trials.
In November 2023, Johnson & Johnson MedTech, a US-based medical-technology company, acquired Laminar Inc. for $400 million. This acquisition strengthens Johnson & Johnson MedTech’s position in the structural-heart and left-atrial-appendage management market by integrating Laminar’s investigational LAAX left-atrial-appendage elimination technology into its portfolio. It also enhances the company’s ability to reduce stroke risk in atrial fibrillation patients through the addition of an innovative implantable cardiac device solution. Laminar Inc. is a US-based manufacturer of implantable cardiac devices.
Major companies operating in the implantable cardiac devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, LifeTech Scientific Corporation, EBR Systems Inc., CVRx Inc., Medico S.p.A., Osypka Medical GmbH, Sorin Group Italia (LivaNova legacy), Shree Pacetronix Ltd., Inpace Medikal, CCC Medical Devices, Imricor Medical Systems Inc., BlueWind Medical Ltd., Vectorious Medical Technologies, Medico Electrodes International Ltd.
North America was the largest region in the implantable cardiac devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the implantable cardiac devices market by increasing costs of imported semiconductors, sensors, batteries, titanium casings, and precision electronic components used in pacemakers and defibrillators. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-value components, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are raising device prices and procurement costs for healthcare providers. However, they are also encouraging domestic production, localized assembly, and regional innovation in implantable cardiac technologies.
The implantable cardiac devices market research report is one of a series of new reports that provides implantable cardiac devices market statistics, including implantable cardiac devices industry global market size, regional shares, competitors with a implantable cardiac devices market share, detailed implantable cardiac devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable cardiac devices industry. This implantable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Implantable cardiac devices are medical instruments that are surgically inserted into the body to assist in the management of heart disorders, especially those associated with irregular heart rhythms (arrhythmias) or heart failure. These devices monitor cardiac activity and often provide electrical impulses to regulate or correct abnormal heartbeats.
The primary categories of implantable cardiac devices consist of pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular implantable cardioverter defibrillators (BI-V ICDs). A pacemaker is a compact medical device positioned beneath the skin in the chest area, designed to manage irregular heartbeats by delivering electrical impulses that prompt the heart to maintain a normal rhythm when its natural pacemaker is inadequate. This device is essential in treating conditions such as bradycardia and various arrhythmias. Applications for these devices encompass bradycardia, tachycardia, heart failure, among others, catering to end users such as hospitals, specialty clinics, and more.
The implantable cardiac devices market consists of sales of products including cardiac resynchronization therapy (CRT) devices, ventricular assist devices (VADs), and implantable heart monitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Implantable Cardiac Devices Market Characteristics
3. Implantable Cardiac Devices Market Supply Chain Analysis
4. Global Implantable Cardiac Devices Market Trends and Strategies
5. Implantable Cardiac Devices Market Analysis of End Use Industries
7. Global Implantable Cardiac Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Implantable Cardiac Devices Total Addressable Market (TAM) Analysis for the Market
9. Implantable Cardiac Devices Market Segmentation
10. Implantable Cardiac Devices Market Regional and Country Analysis
11. Asia-Pacific Implantable Cardiac Devices Market
12. China Implantable Cardiac Devices Market
13. India Implantable Cardiac Devices Market
14. Japan Implantable Cardiac Devices Market
15. Australia Implantable Cardiac Devices Market
16. Indonesia Implantable Cardiac Devices Market
17. South Korea Implantable Cardiac Devices Market
18. Taiwan Implantable Cardiac Devices Market
19. South East Asia Implantable Cardiac Devices Market
20. Western Europe Implantable Cardiac Devices Market
21. UK Implantable Cardiac Devices Market
22. Germany Implantable Cardiac Devices Market
23. France Implantable Cardiac Devices Market
24. Italy Implantable Cardiac Devices Market
25. Spain Implantable Cardiac Devices Market
26. Eastern Europe Implantable Cardiac Devices Market
27. Russia Implantable Cardiac Devices Market
28. North America Implantable Cardiac Devices Market
29. USA Implantable Cardiac Devices Market
30. Canada Implantable Cardiac Devices Market
31. South America Implantable Cardiac Devices Market
32. Brazil Implantable Cardiac Devices Market
33. Middle East Implantable Cardiac Devices Market
34. Africa Implantable Cardiac Devices Market
36. Implantable Cardiac Devices Market Competitive Landscape and Company Profiles
37. Implantable Cardiac Devices Market Other Major and Innovative Companies
40. Implantable Cardiac Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Implantable Cardiac Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses implantable cardiac devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for implantable cardiac devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable cardiac devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Pacemaker; Implantable Cardioverter Defibrillator (ICD); Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)2) By Application: Bradycardia; Tachycardia; Heart Failure; Other Applications
3) By End User: Hospitals; Specialty Clinics; Other End Users
Subsegments:
1) By Pacemaker: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Rate-Responsive Pacemakers2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs; Subcutaneous ICDs
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs; Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Biotronik SE & Co. KG; LivaNova plc; Lepu Medical Technology; MicroPort Scientific Corporation; LifeTech Scientific Corporation; EBR Systems Inc.; CVRx Inc.; Medico S.p.A.; Osypka Medical GmbH; Sorin Group Italia (LivaNova legacy); Shree Pacetronix Ltd.; Inpace Medikal; CCC Medical Devices; Imricor Medical Systems Inc.; BlueWind Medical Ltd.; Vectorious Medical Technologies; Medico Electrodes International Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Implantable Cardiac Devices market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- LivaNova plc
- Lepu Medical Technology
- MicroPort Scientific Corporation
- LifeTech Scientific Corporation
- EBR Systems Inc.
- CVRx Inc.
- Medico S.p.A.
- Osypka Medical GmbH
- Sorin Group Italia (LivaNova legacy)
- Shree Pacetronix Ltd.
- Inpace Medikal
- CCC Medical Devices
- Imricor Medical Systems Inc.
- BlueWind Medical Ltd.
- Vectorious Medical Technologies
- Medico Electrodes International Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.51 Billion |
| Forecasted Market Value ( USD | $ 20.33 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
